EASL 2026
4 stories
-
healthMASLD Redefined: Expert Insights on Multisystem Liver Disease and Future Therapies
Sven Francque discusses the paradigm shift in MASLD treatment at EASL 2026, emphasizing multisystem care, diagnostic gaps, and the future of combination therapies for metabolic liver disease.
-
healthEASL 2026: Rethinking MASLD as a Multisystem Disorder
Sven Francque discusses the paradigm shift in MASLD treatment, emphasizing multisystem care, diagnostic gaps, and individualized pharmacological strategies at EASL 2026.
-
healthGrowing Liver Injury Risk from 'Natural' Wellness Supplements, Experts Warn
EASL 2026 highlights rising cases of herb-induced liver injury linked to dietary supplements, weak regulation, and online wellness myths.
-
healthAlcohol Policy Targets Liver Disease at EASL 2026
Clinicians and policymakers push for clearer labels and stronger regulation to reduce alcohol-related liver disease across Europe.